ISSCA to Host Stem Cell Training Certification Course August 25-26, 2018 in Buenos Aires, Argentina
ISSCA will conduct the next hands-on regenerative medicine certification training course for physicians in Buenos Aires, Argentina, August 25-26. 2018.
MIAMI, April 19, 2018—Following the success of its stem cell training course in Buenos Aires April 6-7, the International Society for Stem Cell Application (ISSCA) has announced plans to host the next hands-on regenerative medicine certification training course for physicians in Buenos Aires August 25-26, 2018.
Eight physicians participated in the April training course, earning certification for harvesting and implanting adipose and bone marrow stem cells in a clinical setting to treat a variety of diseases and conditions including arthritis and osteoarthritis.
Participants learn while they conduct regenerative medicine protocols on live patients under the direction of stem cell training experts. Skills learned in the training course can be used in the physician’s practice for medical and aesthetic treatments and help physicians looking for career advancement opportunities.
Argentinian sports medicine specialist, Damian Ariel Siano M.D., spoke about the benefits of stem cell certification during the training session.
“Now I can offer all my patients a non-surgical option that allows them to avoid surgery for procedures like knee and hip replacement,” Siano says. “For professional athletes, this procedure provides faster recovery and less downtime following the procedure.”
The course also provides participating physicians with access to ISSCA’s online stem cell training course to review all content and procedures introduced during the two-day clinical training course, as well as patient forms and guidelines, procedures, informed consent forms, didactic lectures, training booklets, and more.
The ISSCA’s regenerative medicine protocols training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from patients’ adipose tissue and bone marrow.
Stem cell therapies continue to revolutionize the medical industry and help improve the quality of life for patients suffering from sports injuries, age-related conditions, and other chronic ailments.
The August 25-26. 2018 training course will be held at the Medicine Faculty of Universidad de Buenos Aires.
Seating for this training course is limited. Register today to participate by visiting the Stem Cell Training Buenos Aires website, email info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
Stem cell training certification Buenos Aires
- Published in Press Releases
Platelet-Rich Plasma For Melasma — Will It Fade Forever?
For most women, a tiny pimple on the face is enough to ruin their day. Or week. Even the slightest imperfection that may have a 1% chance of getting noticed by others will freak them out. For these women, Melasma is their darkest nightmare. It’s a pretty common issue, a result of exposure to the sun, that causes brown patches on the face. Permanent patches, I should add.
If you’re suffering from Melasma, the road to “recovery” usually looks like this:
- You hope that it’ll fade away.
- Your friend suggests you try apple cider vinegar and lemon juice treatment.
- Slightly disappointed.
- You visit a dermatologist who’ll prescribe a bleaching cream (hydroquinone or similar).
- Full-on disappointment.
- You Google the hell out of the topic.
- Overwhelm.
- Concealers and makeup become your best friend.
At this point, no one can convince you there is a treatment for getting rid of melasma. Trying more and more treatments only runs the risk of making the condition worse. So what would you do?
What About Platelet-Rich Plasma For Melasma?
According to recent Turkish and Malaysian studies, Platelet-Rich Plasma is showing great promise for melasma. The one good thing about PRP for Melasma is the fact that PRP won’t make the condition worse unlike IPL, Fraxel, or other treatments. So that’s one of the treatments you can confidently try without worry. It’s like getting a natural facial treatment that has a whole lot of potential benefits even if it didn’t help cure melasma.
PRP injections work by supplying growth factors to reduce the pigmentation. And being an independent treatment with no downtime, it can be done in conjunction with conventional treatments for melasma to add and enhance the effects. There are more than 30 bioactive substances in Platelet-Rich Plasma that have separate roles like increasing skin volume and adding new blood vessels to name a few.
Platelet-Rich Plasma with Microneedling
This is the most common combination for Platelet-Rich Plasma therapy. Here’s a video of Dr. Michael Somenek performing a PRP injection on a patient of his immediately after microneedling. The combination is known to have produced results for a lot of varieties of skin pigmentation issues that it’d not be wise for anyone to ignore it for melasma, especially when creams and peels didn’t help. More important is PRP’s ability to stimulate collagen production in the area so it tightens the pores and makes your skin glowing.
Why Platelet-Rich Plasma?
PRP is primarily a healing vehicle. It needs to be injected into the membrane below the skin. The way it works is by supplying the underlying skin membrane with collagen and tenascin stimulated by the transforming growth factors in PRP. These growth factors also promote the formation of new blood vessels that in some cases results in the disappearance of spider veins.
The released growth factors (mainly platelet-derived growth factor (PDGF), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and transforming growth factor-beta (TGF-ß)) can stimulate the proliferation of fibroblasts and epidermal cells, and collagen synthesis. In addition, the transforming growth factor-beta (TGF-ß) has been proven to inhibit melanogenesis — or reverse skin pigmentation — the exact opposite effect of exposure to UV-B radiation.
Typically, patients see excellent results with 2-3 PRP injections in the first 3 months. And clinical studies have shown that it will maintain after 6 months. However, Melasma is known to recur even after successful treatments. So you must take precautions against it by using sunscreen with broad-spectrum protection and an SPF of 30 or higher. And avoid skincare products that are harsh as they can exacerbate melasma.
- Published in Corporate News / Blog
Aesthetic Practice Digital Marketing, Regenerative Medicine Master Classes at Jornadas Mediteraneas
ISSCA to host regenerative medicine symposium during Jornadas Mediteraneas—Mediterranean Days of Therapeutic Confrontations in Medicine and Cosmetic Surgery—in Barcelona.
MIAMI, April 2, 2018—The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium during Jornadas Mediteraneas—Mediterranean Days of Therapeutic Confrontations in Medicine and Cosmetic Surgery— in Barcelona, Spain May 13, 2018.
The ISSCA symposium will provide a platform for Global Stem Cells Group to conduct master classes in digital marketing for aesthetic practices and regenerative medicine, conducted by specialists in these fields.
Benito Novas, Global Stem Cells Group CEO
GSCG CEO Benito Novas will conduct a master class in digital marketing for aesthetic physicians. Novas, a global entrepreneur and medical marketing professional in the fields of biotechnology, life sciences, and healthcare development, will share his expertise and the latest marketing tools for managing an aesthetic medicine practice. Topics will include social media strategies for promoting physician practices, and how to design Google and Facebook ads that generate targeted leads and engage new potential patients.
Novas’s class will provide aesthetic medicine professionals with a valuable opportunity to learn about the most effective marketing resources and methods for growing an aesthetic medicine practice and best practices for managing different advertising resources.
In addition, Novas’s class will offer expert tips for using content marketing strategies to build a practice. Following the class, Novas will launch his newest book, “Marketing Digital en su clinica Estetica”(“Digital Marketing in Your Aesthetics Clinic”) as well as his new online course, “Digital Marketing for Aesthetic Physicians.
DRA Maritza Novas
The second master class will focus on regenerative medicine and will be split into two sessions, the first of which will be conducted by stem cell specialist DRA Maritza Novas and anti-aging and regenerative medicine specialist Leslie Mesen, M.D.
Novas and Mesen will offer instruction on adult stem cells, which have attracted the attention of scientists and physicians worldwide for their unique biological properties and potential for treating disease, injuries, and medical conditions. Stem cell research is complex and fast-growing, with new developments progressing rapidly.
Novas will share her expertise, experiences, and perspective on a broad range of topics regarding advancements in mesenchymal stem cell (MSC) applications during their transition from bench side to bedside.
Leslie Mesen, M.D.
The second session will feature Mesen, Medical Director of Stem Cells Costa Rica who is board certified in anti-aging and regenerative medicine by The American Academy of Anti-Aging Medicine, and DRA Mar Vargas, Director of the Lasar Sculpture Medical Clinic in Escazu, Costa Rica, who will present their insights regarding clinical applications of stem cell treatments and share information about their clinical experiences with symposium audience members.
DRA Mar Vargas, Lasar Sculpture Medical Clinic
Sponsored by ISSCA, the symposium will utilize the Jornadas Mediteraneas platform to continue its mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research.
To learn more about the symposium and digital marketing masterclass and to make a reservation, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training. and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical
corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Jornadas Mediteraneas master classes
- Published in Press Releases
ISSCA President Deyoung Kim, Ph.D., Announces Regenerative Medicine Symposium in Korea Nov. 24, 2018
ISSCA Founder and President Daeyong Kim, Ph.D., announces plans to host the Regenerative Medicine Cell Therapies Symposium in Seoul, Korea in November.
MIAMI, April 2, 2018—International Association for Stem Cell Application (ISSCA) President Daeyong Kim, Ph.D., has announced plans to host Applications of Cell Therapies in Medicine and Aesthetic Surgery, a regenerative medicine symposium, in Seoul Korea November 24, 2018.
The symposium will be ISSCA’s principal event for 2018, during which the organization will launch its entire 2019 program, including stem cell certification courses for physicians to be held in locations worldwide, as well as the 2019 regenerative medicine symposium agenda.
In 2019, ISSCA plans to expand its activities to Asia by hosting at least one regenerative medicine symposium and four stem cell certification courses during the year. The Korea symposium will be structured as a scientific meeting in which regenerative medicine practitioners share their clinical experience. ISSCA affiliate Global Stem Cells Group, and biomedical and leading lab equipment manufacturer N-Biotek will launch new technology for regenerative medicine practitioners.
The international symposium is part of ISSCA’s mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research. The Buenos Aires event will host a group of renowned international speakers in the field of stem cell and regenerative medicine, who will offer a day of rigorous scientific discourse aimed at physicians.
Topics of focus at the symposium include:
- Management of aging at the cellular level
- Stem cell therapies in medical aesthetics: the latest methods of harvest and isolation Non-invasive protocols of non-surgical facial and body rejuvenation
- Beyond fillers and toxins
- Combined treatment plans that include surgical methods for the management of advanced aging
- Restoration and assisted hair transplantation with biomaterials and growth factors
- The invaluable role of biological cosmeceutical in the management of aging
- The aging process from the inside out: the role of hormones
- Management of the latest digital marketing tools for recruiting patients in their aesthetic clinics
The symposium will incorporate the biology, medicine, applications, regulations, product development, and commercialization of stem cells. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed.
To learn more about the ISSCA Korea symposium and to make a reservation, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training. and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
ISSCA Korea regenerative medicine symposium
- Published in Press Releases
ISSCA to Host Regenerative Medicine Symposium in Buenos Aires, Argentina August 24, 2018
Image: Facultad de Medicina – Universidad de Buenos Aires
ISSCA will host Applications of Cell Therapies in Medicine and Aesthetic Surgery, a regenerative medicine symposium in Buenos Aires, Argentina, August 24, 2018.
MIAMI, March 18, 2018—The International Association for Stem Cell Application (ISSCA) has announced plans to host Applications of Cell Therapies in Medicine and Aesthetic Surgery, a regenerative medicine symposium. In Buenos Aires, Argentina August 24, 2018.
The international symposium is part of ISSCA’s mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research. The Buenos Aires event will host a group of renowned international speakers in the field of stem cell and regenerative medicine, who will offer a day of rigorous scientific discourse aimed at physicians.
Topics of focus at the symposium include:
- Management of aging at the cellular level
- Stem cell therapies in medical aesthetics: the latest methods of harvest and isolation Non-invasive protocols of non-surgical facial and body rejuvenation
- Beyond fillers and toxins
- Combined treatment plans that include surgical methods for the management of advanced aging
- Restoration and assisted hair transplantation with biomaterials and growth factors
- The invaluable role of biological cosmeceutical in the management of aging
- The aging process from the inside out: the role of hormones
- Management of the latest digital marketing tools for recruiting patients in their aesthetic clinics
The symposium will incorporate the biology, medicine, applications, regulations, product development, and commercialization of stem cells. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed.
The event will be held at the Facultad de Medicina – Universidad de Buenos Aires
To learn more about the ISSCA Buenos Aires symposium and to make a reservation, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training. and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
ISSCA Buenos Aires Regenerative Medicine Symposium
- Published in Press Releases
ISSCA Founder Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D. to speak at Istanbul Symposium
ISSCA Founder Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D. to speak at the Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey, April 28, 2018.
MIAMI, March 18, 2018—ISSCA Founder and General Director Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D. will be keynote speakers at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Kim will discuss stem cell therapies for diabetes, and Gilani will speak on the effect of autologous bone marrow-derived stem cells treatments on knee osteoarthritis.
Daeyong Kim, Ph.D.
Kim, a Global Stem Cells Group Advisory Board member, is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment and leader of stem cell technology solutions for providers worldwide.
Additionally, Kim is vice-president of BioChip Society, CEO of GTOP Construction Inc, managing director Woojoo Telecom, and managing director of KEPCO KDN.
In 2013, Kim completed an international business course at UC Berkeley, U.S. and received and an M.D. in alternative medicine at IBAM, India. In 2016, he received a Ph.D. in adipose-derived stem cell research at Westminster University in Korea.
Gilani is the Founder, CEO and Stem Cell/Regenerative Medicine Consultant for The Institute of Regenerative Medicine in Rawalpindi, Pakistan, the first-of-its-kind regenerative medicine institute in Pakistan that caters to clinical applications of stem cell and other regenerative medicine treatments. The institute also serves as a center of excellence in training physicians and paramedic staff in regenerative medicine in Pakistan.
Syed Salman Naeem Gilani, M.D.
In 2000, Gilani received his medical degree from Rawalpindi Medical College, Punjab University and completed a Fellowship in Stem Cell Therapy from the American Board of Anti-aging and Regenerative Medicine. He is ECFMG certified, a member of the American Academy of Anti-Aging and Regenerative Medicine, and a Diplomat of the American Academy of Aesthetic Medicine.
The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.
The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.
To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today. For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About International Society for Stem Cell Application (ISSCA):
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.
- Published in Press Releases
R. Gökmen Turan M.D., Ph.D. and Mahir Mahirogullari, M.D. to speak at ISSCA Symposium in Istanbul April 28
ISSCA names R. Gökmen Turan M.D., Ph.D., and Mahir Mahirogullari, M.D. keynote speakers at the Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey, April 28, 2018.
MIAMI, March 18, 2018— R. Gökmen Turan M.D., Ph.D. and Mahir Mahirogullari, M.D. will be featured speakers at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Turan will speak on therapeutic applications of stem cells in heart failure, and Mahirogullari will discuss cartilage treatment combining stem cells and biomedical scaffolds.
R. Gökmen Turan M.D., Ph.D.
Turan is a cardiologist and head of the Structural Heart Disease Department of Internal Medicine, Division of Cardiology at Porz Hospital, University Hospital of Cologne and University of Witten/Herdecke Germany.
Mahirogullari is an orthopedic surgeon specializing in sports medicine and traumatology. He currently serves as a professor at Memorial Health Group in İstanbul, Turkey.
His focus includes multi-ligament injuries and cartilage repair of the knee; arthroplasty of the knee, hip and shoulder; arthroscopy of the knee, shoulder, hip, ankle and elbow joints; surgery of instability and cuff tear of the shoulder; orthopedic trauma, and the application of platelet-rich plasma (PRP), bone marrow aspirate stem cells and adipose-derived stem cells for treatment of orthopedic pathologies especially cartilage injuries.
Mahir Mahirogullari. M.D.
Mahirogullari received his medical degree (M.D.) from Gülhane Military Medical Academy School of Medicine in Ankara, Turkey in 1992 and completed his residency at GATA Haydarpasa Training Hospital in Istanbul.
He served as a general practitioner and orthopedic surgeon, treating and managing multi-trauma patients and war injuries. He also served with KFOR, NATO in Kosovo for six months. He worked as a Fellow with arthroscopic shoulder, knee, and trauma specialist Gary G. Poehling, M.D. in Winston Salem, North Carolina for one year before joining the faculty at Istanbul Medipol University School of Medicine in 2012 as chairman of the Department of Orthopedic Surgery. He has worked within the Memorial Health Group in Istanbul since 2016.
Mahirogullari is a member of The Turkish Society of Orthopedics and Traumatology (TOTBİD), The Turkish Society of Arthroscopy Knee Surgery & Orthopedics Sport Medicine (TUSYAD), The International Society of Arthroscopy Knee Surgery & Orthopedics Sport Medicine (ISAKOS), The Turkish Society of Shoulder and Elbow Society, The European Society of Sports Traumatology Knee Surgery and Arthroscopy (ESSKA 2000), The Turkish Board Certificate, and The Turkish Society of Hip and Knee Arthroplasty.
The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.
The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.
To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today. For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About International Society for Stem Cell Application (ISSCA):
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
R. Gökmen Turan M.D., Ph.D. and Mahir Mahirogullari, M.D.
- Published in Press Releases
ISSCA to Host New Stem Cell Training Course May 25-26, 2018 in Bogota, Colombia
Image: Bogota, Colombia
ISSCA will conduct the next hands-on regenerative medicine certification training course for physicians in Bogota, Colombia May 25-26, 2018.
MIAMI, Nov. 20, 2017—The International Society for Stem Cell Application (ISSCA) announced plans to hold its next hands-on regenerative medicine certification training course for physicians in Bogota, Colombia May 25-26, 2018.
Plans for the next training workshop follow the success of the organization’s first Bogota-based course held March 2-3, 2018 and attended by eight physicians from three countries—Spain, Colombia, and Ecuador.
Stem cell training
The two-day, intensive training course teaches participating physicians how to harvest stem cells from adipose and bone marrow tissue. Participants learn while they conduct regenerative medicine protocols on live patients under the direction of stem cell training experts. Skills learned in the training course can be used to treat a variety of medical and aesthetic conditions such as osteoarthritis and facial rejuvenation.
Once certified, practitioners learn can use the techniques learned to treat patients in their practices and in clinical settings for career advancement. The course provides participating physicians with access to ISSCA’s online stem cell training course to review all content and procedures introduced during the two-day clinical training course, as well as patient forms and guidelines, procedures, informed consent forms, didactic lectures, training booklets, and more.
The ISSCA regenerative medicine protocols training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells derived from patients’ adipose tissue and bone marrow.
Stem cell therapies continue to revolutionize the anti-aging aesthetics industry and help improve the quality of life for patients suffering from some chronic conditions.
Seating for this training course is limited. Register today to participate by visiting the Stem Cell Training Course Bogota website, email info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
Stem cell training Bogota
- Published in Press Releases
Mehmet Veli Karaaltın M.D. and Mehmet Bozourt, M.D. to speak at ISSCA Symposium in Istanbul April 28
ISSCA announces keynote speakers Mehmet Veli Karaaltın, M.D. and Mehmet Bozkurt, M.D. at the Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey, April 28.
MIAMI, March 18, 2018— Mehmet Veli Karaaltın M.D. and Mehmet Bozkurt, M.D. will be featured speakers at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Karaaltın will speak on the role of cellular therapy and futuristic applications in plastic reconstructive surgery: from anti-aging to reconstructive surgery (level evidence IV). Bozkurt will discuss the application of regenerative cells on immunologic and diabetic wounds and severe burns.
Mehmet-Veli-Karaaltın, M.D.
Karaaltın, a Global Stem Cells Group advisory board member, specializes in head and maxillofacial surgery and hand surgery, and serves as an associate professor of plastic aesthetic & reconstructive surgery (European Board Certified) at Hacettepe University Medical Faculty in Ankara, Turkey.
After graduating from Istanbul University’s Cerrahpaşa English Medical Faculty, Karaaltın completed a national examination from Hacettepe University in Ankara, Turkey, placing 12th out of 25,000 doctoral candidates. He later completed all exam requirements of the European Society of Plastic Surgery. He is a member of the European Council of Plastic Reconstructive and Aesthetic Surgery and the International Society of Aesthetic Plastic Surgery (ISAPS).
In addition to his work in aesthetic applications, Karaaltın is also known for his work in microvascular free flaps, nerve transfers, facial surgery, and tissue transplants. He also practices cellular therapy and tissue regeneration for healing diabetic wounds, severe burns, and Buerger’s disease. He is one of only a few physicians in the world who offer surgical treatment for Lymphedema-Elephant Disease with microvascular lymph node transfer.
Mehmet Bozkurt, M.D.
Bozkurt is a plastic and reconstructive surgeon and serves as chairman and director of the plastic reconstructive surgery and burn center at Kartal Dr. Lütfi Kırdar Training and Research Hospital in Istanbul. He completed his clinical fellowship in microsurgery at Cleveland Clinic in 2012. Bozkurt is a member of The International Federation for Adipose Therapeutics and Science, The İnternational Society of Burn Association, and The Turkish Aesthetic Surgery Association. He is board certified in European plastic surgery and Turkish plastic surgery.
He completed medical school in July 1995 at the Gulhane Military Medical Academy Faculty of Medicine in Ankara, Turkey and completed post-graduate studies and training in emergency medicine, microsurgery, plastic and reconstructive surgery, orthopedic medicine, and preventative medicine. He is the recipient of numerous honors and awards in his field.
The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.
The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.
To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today. For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About International Society for Stem Cell Application (ISSCA):
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
Mehmet Veli Karaaltın M.D. and Mehmet Bozourt, M.D.
- Published in Press Releases
Adimarket named distributor for Prostemics’ AAPE regenerative stem cell skin and hair products
Global Stem Cells Group affiliate Adimarket is named official distributor of Prostemics’ advanced adipose-derived stem cell protein extract (AAPE) biologic products.
MIAMI, March 18, 2018—Global Stem Cells Group subsidiary Adimarket has been named the official distributor of advanced adipose-derived stem cell protein extract (AAPE) products manufactured by Prostemics.
AAPE hair and skin care products, available through Adimarket’s online regenerative medicine store, leverage the regenerative power of stem cells for use in anti-aging and restorative skin and hair products by utilizing medical techniques to extract, manipulate, and process adipose-derived stem cells.
AAPE product benefits:
Skin care
More than 800 types of human protein extracts in stem cells provide superior biological activity to boost cell repair and improve skin elasticity that is lost in the natural aging process. AAPE can be applied in various areas of clinical treatment with MTS and laser for anti-wrinkle, anti-oxidation, wound healing, and whitening effects. In Japan, more than 200 dermatologic clinics use AAPE for skin rejuvenation. AAPE is approved by dermatologists and medical professionals in the U.S., Korea, and Japan. Since it is extracted from human adipose-derived stem cells, AAPE is considered very safe, effective, and powerful for anti-aging skin care regimens.
Hair care:
AAPE hair care serum is a non-invasive treatment that can be applied in a clinical setting without discomfort or downtime as a hair loss treatment.
The serum’s adipose or fat tissue content provides large numbers of mesenchymal stem cells (MSCs) which are located within the stromal vascular fraction (SVF) which contains powerful regenerative stem and stromal cells, progenitor cells, growth factors and many other powerful biologic components that work to regenerate cell growth.
AAPE hair treatments can be used with PRP or Platelet Rich Plasma. Like PRP, recent scientific literature supports the use of adipose-derived stem cells to help enhance hair growth from weak hair follicles.
About Adimarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
###
AAPE products
- Published in Press Releases
